A histopathological study of pulmonary hypertension in connective tissue disease

Allergology International

Volumn 60, Issue 4, 2011, Pages 411-417

  Sasaki, Nobuhito ^a   Kamataki, Akihisa ^a   Sawai, Takashi ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Autopsy; Connective tissue disease; Histopathology; Mixed connective tissue disease; Pulmonary hypertension

Indexed keywords

ARTERY INTIMA PROLIFERATION; AUTOPSY; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIUM INJURY; HISTOPATHOLOGY; HUMAN; INCIDENCE; LUNG BLOOD FLOW; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASCULITIS;

EID: 83455230720     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.11-RAI-0337     Document Type: Review

References (20)

1. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66: 940-4.
2. Lynch DA. Lung disease related to collagen vascular disease. J Thorac Imaging 2009;24:299-309.
3. Simonneau G, Robbins IM, Beghetti M et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54 (1 Suppl):S43-54.
4. Yoshida S, Katayama M. [Pulmonary hypertension in patients with connective tissue diseases]. Nihon Rinsho [Jpn J Clin Med] 2001;59:1164-7(in Japanese).
5. Mukerjee D, St George D, Coleiro B et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-93.
6. Vegh J, Szodoray P, Kappelmayer J et al. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension. Scand J Immunol 2006;64:69-76.
7. Funauchi M, Shimadzu H, Tamaki C et al. Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center. Rheumatol Int 2007;27:243-9.
8. Kuramochi S, Yoshimura Y. [Lesions of interstitial pneumonia in connective tissue diseases]. Byori to Rinsho [Pathol Clin Med] 1990;8:1512-7(in Japanese).
9. Kondo H, Ishikawa A. [Mixed connective tissue disease]. Nihon Rinsho [Jpn J Clin Med] 2002;60(Suppl 1):397-403 (in Japanese).
10. Yoshimura Y, Hosoda Y. [Mixed connective tissue disease]. Byori to Rinsho [Pathol Clin Med] 1990;8:1518-22 (in Japanese).
11. Sawai T, Murakami K, Kasukawa R, Kyogoku M. Histopathological study of mixed connective tissue disease from 32 autopsy cases in Japan. Modern Rheumatology 1997;7: 279-92.
12. Sasaki N, Kurose A, Inoue H, Sawai T. [A possible role of anti-endothelial cell antibody in the sera of MCTD patients on pulmonary vascular damage relating to pulmonary hypertension]. Ryumachi 2002;42:885-94(in Japanese).
13. Ward JP, McMurtry IF. Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem. Curr Opin Pharmacol 2009;9:287-96.
14. Isern RA, Yaneva M, Weiner E et al. Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med 1992;93:307-12.
15. Sanchez O, Sitbon O, Jaïs X, Simonneau G, Humbert M. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 2006;130:182-9.
16. Jais X, Launay D, Yaici A et al. Immunosuppressive therapy in lupus-and mixed connective tissue diseaseassociated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum 2008; 58:521-31.
17. Yoshio T, Masuyama J, Sumiya M, Minota S, Kano S. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1994;21:2058-63.
18. Tamby MC, Chanseaud Y, Humbert M et al. Antiendothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 2005;60:765-72.
19. Yoshio T, Masuyama J, Mimori A, Takeda A, Minota S, Kano S. Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus. Ann Rheum Dis 1995;54:361-5.
20. Coghlan JG, Pope J, Denton CP. Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease. Curr Opin Pulm Med 2010;16 (Suppl 1):S27-34.